33192455|t|Correlation of Serum BACE1 With Emergence Delirium in Postoperative Patients: A Preliminary Study.
33192455|a|Background: The mechanism underlying delirium, a common acute fluctuating mental state, may be related to the activation of a neuroinflammatory response. In this study, we attempted to investigate whether plasma inflammatory response markers, vascular and cerebrovascular injury-related markers, and neurodegeneration-associated markers were associated with emergence delirium (ED). Methods: Patients aged 50 years or above who underwent elective laparoscopic surgery under general anesthesia were included in this study. Delirium was assessed postoperatively with the Richmond Agitation Sedation Scale (RASS) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scale. Plasma samples were collected from ED patients and non-ED patients to test concentrations of inflammation markers, including interleukin 6 (IL-6), chitinase 3-like 1 (CHI3L1), S100 calcium-binding protein B (S100B), lipoprotein-associated phospholipase-A2 (Lp-PLA2), and macrophage migration inhibitory factor (MIF); vascular and cerebrovascular injury-related markers, including intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1); and neurodegeneration-associated markers, including alpha-synuclein (alpha-Syn) and beta-secretase 1 (BACE1). Binary logistic regression analysis was performed to analyze the relationship between biomarkers and ED, and receiver operating characteristic (ROC) curves were used to analyze the diagnostic value of biomarkers. Results: A total of 104 patients were included in this study, with an average age of 63.69 +- 7.21. IL-6 (OR = 2.73, 95% CI: 1.66-6.44, P = 0.022), S100B (OR = 4.74, 95% CI: 1.88-11.95, P = 0.001), and BACE1 (OR = 6.54, 95% CI: 2.57-16.65, P < 0.000) were independent biological indicators for the occurrence of ED.CHI3L1, Lp-PLA2, MIF, ICAM-1, VCAM-1, and alpha-Syn were unrelated to ED. Plasma BACE1 level had a possible diagnostic value for ED [area under curve (AUC) = 0.75, 95% CI: 0.66-0.85], whereas plasma IL-6 (AUC = 0.62, 95% CI: 0.51-0.73) and S100B (AUC = 0.65, 95% CI: 0.54-0.76) levels had little diagnostic value for distinguishing ED vs. non-ED. Conclusion: Higher levels of systemic inflammation marker IL-6, cerebral inflammation marker S100B, and neurodegeneration-associated marker BACE1 are related to ED. Plasma BACE1 may be a potential diagnostic biomarker for ED.
33192455	21	26	BACE1	Gene	23621
33192455	32	50	Emergence Delirium	Disease	MESH:D000071257
33192455	68	76	Patients	Species	9606
33192455	136	144	delirium	Disease	MESH:D003693
33192455	225	242	neuroinflammatory	Disease	MESH:D000090862
33192455	311	323	inflammatory	Disease	MESH:D007249
33192455	342	377	vascular and cerebrovascular injury	Disease	MESH:D057772
33192455	399	416	neurodegeneration	Disease	MESH:D019636
33192455	457	475	emergence delirium	Disease	MESH:D000071257
33192455	477	479	ED	Disease	MESH:D000071257
33192455	491	499	Patients	Species	9606
33192455	621	629	Delirium	Disease	MESH:D003693
33192455	825	827	ED	Disease	MESH:D000071257
33192455	828	836	patients	Species	9606
33192455	845	847	ED	Disease	MESH:D000071257
33192455	848	856	patients	Species	9606
33192455	883	895	inflammation	Disease	MESH:D007249
33192455	915	928	interleukin 6	Gene	3569
33192455	930	934	IL-6	Gene	3569
33192455	937	955	chitinase 3-like 1	Gene	1116
33192455	957	963	CHI3L1	Gene	1116
33192455	966	996	S100 calcium-binding protein B	Gene	6285
33192455	998	1003	S100B	Gene	6285
33192455	1006	1045	lipoprotein-associated phospholipase-A2	Gene	7941
33192455	1047	1054	Lp-PLA2	Gene	7941
33192455	1061	1099	macrophage migration inhibitory factor	Gene	4282
33192455	1101	1104	MIF	Gene	4282
33192455	1107	1142	vascular and cerebrovascular injury	Disease	MESH:D057772
33192455	1170	1208	intercellular cell adhesion molecule-1	Gene	3383
33192455	1210	1216	ICAM-1	Gene	3383
33192455	1255	1261	VCAM-1	Gene	7412
33192455	1268	1285	neurodegeneration	Disease	MESH:D019636
33192455	1316	1331	alpha-synuclein	Gene	6622
33192455	1333	1342	alpha-Syn	Gene	6622
33192455	1348	1364	beta-secretase 1	Gene	23621
33192455	1366	1371	BACE1	Gene	23621
33192455	1475	1477	ED	Disease	MESH:D000071257
33192455	1611	1619	patients	Species	9606
33192455	1687	1691	IL-6	Gene	3569
33192455	1735	1740	S100B	Gene	6285
33192455	1789	1794	BACE1	Gene	23621
33192455	1899	1908	ED.CHI3L1	Disease	MESH:D000071257
33192455	1910	1917	Lp-PLA2	Gene	7941
33192455	1919	1922	MIF	Gene	4282
33192455	1924	1930	ICAM-1	Gene	3383
33192455	1932	1938	VCAM-1	Gene	7412
33192455	1944	1953	alpha-Syn	Gene	6622
33192455	1972	1974	ED	Disease	MESH:D000071257
33192455	1983	1988	BACE1	Gene	23621
33192455	2031	2033	ED	Disease	MESH:D000071257
33192455	2101	2105	IL-6	Gene	3569
33192455	2142	2147	S100B	Gene	6285
33192455	2234	2236	ED	Disease	MESH:D000071257
33192455	2245	2247	ED	Disease	MESH:D000071257
33192455	2287	2299	inflammation	Disease	MESH:D007249
33192455	2307	2311	IL-6	Gene	3569
33192455	2313	2334	cerebral inflammation	Disease	MESH:D007249
33192455	2342	2347	S100B	Gene	6285
33192455	2353	2370	neurodegeneration	Disease	MESH:D019636
33192455	2389	2394	BACE1	Gene	23621
33192455	2410	2412	ED	Disease	MESH:D000071257
33192455	2421	2426	BACE1	Gene	23621
33192455	2471	2473	ED	Disease	MESH:D000071257
33192455	Association	MESH:D000071257	3569
33192455	Association	MESH:D057772	7412
33192455	Association	MESH:D019636	6622
33192455	Association	MESH:D057772	3383
33192455	Association	MESH:D007249	6285
33192455	Association	MESH:D007249	4282
33192455	Association	MESH:D019636	23621
33192455	Association	MESH:D007249	7941
33192455	Association	MESH:D000071257	6285
33192455	Association	MESH:D000071257	3383
33192455	Association	MESH:D000071257	23621

